Identification and management of fetuses at risk for, or affected by, congenital heart block associated with autoantibodies to SSA (Ro), SSB (La), or an HsEg5-like autoantigen

Rheumatology International

Volumn 26, Issue 10, 2006, Pages 886-895

  Claus, Renate ^a   Hickstein, Heiko ^a   Külz, Thomas ^a   Lenschow, Ute ^a   Meiske, Doris ^a   Kotitschke, Andrea ^a   Thiesen, Hans Jürgen ^a   Lorenz, Peter ^a  

^a UNIVERSITY OF ROSTOCK   (Germany)

Author keywords

Autoantibodies; Congenital heart block; HsEg5 (NuMA 2); Plasmapheresis immunoadsorption; SSA (Ro); SSB (La)

Indexed keywords

AUTOANTIGEN; DEXAMETHASONE; HSEG5 LIKE AUTOANTIGEN; IMMUNOGLOBULIN G; LA ANTIBODY; RO ANTIBODY; UNCLASSIFIED DRUG;

ADULT; ANTIBODY DETECTION; ARTICLE; CASE REPORT; CONGENITAL HEART BLOCK; CONGENITAL HEART MALFORMATION; DELIVERY; DISEASE EXACERBATION; FEMALE; FETUS; FETUS HYDROPS; FETUS RISK; GESTATION PERIOD; HEART PACING; HIGH RISK PREGNANCY; HUMAN; HUMAN CELL; IMMUNOADSORPTION; PLACENTA; PREGNANT WOMAN; PRENATAL SCREENING; PRIORITY JOURNAL; RARE DISEASE; RECURRENT ABORTION; SJOEGREN SYNDROME;

AUTOANTIBODIES; AUTOANTIGENS; FEMALE; FETAL DEATH; FETAL DISEASES; FOLLOW-UP STUDIES; HEART BLOCK; HUMANS; IMMUNITY, MATERNALLY-ACQUIRED; INFANT, NEWBORN; PLASMAPHERESIS; PREGNANCY; PREGNANCY COMPLICATIONS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 33745500453     PISSN: 01728172     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00296-005-0101-4     Document Type: Article

References (56)

1. Brucato A, Jonzon A, Friedman D, Allan LD, Vignati G, Gasparini M, Stein JI, Montella S, Michaelsson M, Buyon J (2003) Proposal for a new definition of congenital complete atrioventricular block. Lupus 12:427-435
2. Buyon JP, Clancy RM (2003) Neonatal lupus: review of proposed pathogenesis and clinical data from the US-based Research Registry for Neonatal Lupus. Autoimmunity 36:41-50
3. Julkunen H, Miettinen A, Walle TK, Chan EK, Eronen M (2004) Autoimmune response in mothers of children with congenital and postnatally diagnosed isolated heart block: a population based study. J Rheumatol 31:183-189
4. Buyon JP, Waltuck J, Caldwell K, Crawford B, Slade SG, Copel J, Chan EKL (1994) Relationship between maternal and neonatal levels of antibodies to 48-kDa SSB (La), 52-kDa SSA (Ro), and 60-kDa SSA (Ro) in pregnancies complicated by congenital heart block. J Rheumatol 21:1943-1947
5. Tseng CE, Buyon JP (1997) Neonatal lupus syndromes. Rheum Dis Clin North Am 23:31-54
6. Horsfall AC, Venables PJ, Taylor PV, Maini RN (1991) Ro and La antigens and maternal anti-La idiotype on the surface of myocardial fibres in congenital heart block. J Autoimmun 4:165-176
7. Reichlin M, Brucato A, Frank MB, Maddison PJ, McCubbin VR, Wolfson-Reichlin M, Lee LA (1994) Concentration of autoantibodies to native 60-kd Ro/SS-A and denatured 52-kd Ro/SS-A in eluates from the heart of a child who died with congenital complete heart block. Arthritis Rheum 37:1698-1703
8. Garcia S, Nascimento JHM, Bonfa E, Levy R, Oliveira SF, Tavares AV, Campos de Carvalho AC (1994) Cellular mechanisms of the conduction abnormalities induced by serum from anti-Ro/SSA-positive patients in rabbits hearts. J Clin Invest 93:718-724
9. Boutjdir M, Chen L, Zhang Z-H, Tseng C-E, DiDonato F, Rashbaum W, Morris A, El-Sherif N, Buyon JP (1997) Arrhythmogenicity of IgG and anti-52-kD SSA/Ro affinity-purified antibodies from mothers of children with congenital heart block. Circ Res 80:354-362
10. Mazel JA, El-Sherif N, Buyon JP, Boutjdir M (1999) Electrocardiographic abnormalities in a murine model injected with IgG from mothers of children with congenital heart block. Circulation 99:1914-1918
11. Miranda-Carús ME, Boutjdir M, Tseng C-E, DiDonato F, Chan EKL, Buyon JP (1998) Induction of antibodies reactive with SSA/Ro-SSB/La and development of congenital heart block. J Immunol 161:5886-5892
12. Salomonsson S, Sonesson S, Ottosson L, Muhallab S, Olsson T, Sunnerhagen M, Kuchroo VK, Thorén P, Herlenius E, Wahren-Herlenius M (2005) Ro/SSA autoantibodies directly bind cardiomyocytes, disturb calcium homeostasis, and mediate congenital heart block. J Exp Med 201:11-17
13. Miranda ME, Tseng CE, Rashbaum W, Ochs RL, Casino CA, Di Donato F, Chan EK, Buyon JP (1998) Accessibility of SSA/Ro and SSB/La antigens to maternal autoantibodies in apoptotic human fetal cardiac myocytes. J Immunol 161:5061-5069
14. Ayukawa K, Taniguchi S, Masumoto J, Hashimoto S, Sarvotham H, Hara A, Aoyama T, Sagara J (2000) La autoantigen is cleaved in the COOH terminus and loses the nuclear localization signal during apoptosis. J Biol Chem 275:34465-34470
15. Baboonian C, Venables PJ, Booth J, Williams DG, Roffe LM, Maini RN (1989) Virus infection induces redistribution and membrane localization of the nuclear antigen La (SS-B): a possible mechanism for autoimmunity. Clin Exp Immunol 78:454-459
16. Furukawa F, Lyons MB, Lee LA, Coulter SN, Norris DA (1988) Estradiol enhances binding to cultured human keratinocytes of antibodies specific for SS-A/Ro and SS-B/La. Another possible mechanism for estradiol influence of lupus erythematosus. J Immunol 141:1480-1488
17. Horsfall AC, Rose LM (1992) Cross-reactive maternal autoantibodies and congenital heart block. J Autoimmun 5:479-493
18. Qu Y, Xiao G-Q, Chen L, Boutjdir M (2001) Autoantibodies from mothers of children with congenital heart block downregulate cardiac L-type Ca channels. J Mol Cell Cardiol 33:1153-1163
19. Scofield RH, Dickey WD, Jackson KW, James JA, Harley JB (1991) A common autoepitope near the carboxyl terminus of the 60-kD Ro ribonucleoprotein: sequence similarity with a viral protein. J Clin Immunol 11:378-388
20. Clancy RM, Kapur RP, Molad Y, Askanase AD, Buyon JP (2004) Immunohistologic evidence supports apoptosis, IgG deposition, and novel macrophage/fibroblast crosstalk in the pathologic cascade leading to congenital heart block. Arthritis Rheum 50:173-182
21. Herreman G, Galezowski N (1985) Maternal connective tissue disease and congenital heart block (letter). N Engl J Med 312:1329
22. Alexander E, Buyon JP, Provost TT, Guarnieri T (1992) Anti-Ro/SS-A antibodies in the pathophysiology of congenital heart block in neonatal lupus syndrome, an experimental model. Arthritis Rheum 35:176-189
23. Sonesson SE, Salomonsson S, Jacobsson LA, Bremme K, Wahren-Herlenius M (2004) Signs of first-degree heart block occur in one-third of fetuses of pregnant women with anti-SSA/Ro 52-kd antibodies. Arthritis Rheum 50:1253-1261
24. Brucato A, Frassi M, Franceschini F, Cimaz R, Faden D, Pisoni MP, Muscara M, Vignati G, Stramba-Badiale M, Catelli L, Lojacono A, Cavazzana I, Ghirardello A, Vescovi F, Gambari PF, Doria A, Meroni PL, Tincani A (2001) Risk of congenital complete heart block in newborns of mothers with anti-Ro/SSA antibodies detected by counterimmunoelectrophoresis: a prospective study of 100 women. Arthritis Rheum 44:1832-1835
25. Solomon DG, Rupel A, Buyon JP (2003) Birth order, gender and recurrence rate in autoantibody-associated congenital heart block: implications for pathogenesis and family counseling. Lupus 12:646-647
26. Hickstein H, Külz T, Claus R, Stange J, Schmidt R (2005) Autoimmune-associated congenital heart block: treatment of the mother with immunoadsorption. Ther Apher Dial 9:148-153
27. Vitali C, Bombardieri S, Moutsopoulos HM, Balestrieri G, Bencivelli W, Bernstein RM et al (1993) Preliminary criteria for the classification of the Sjögren's syndrome: results of a prospective concerted action supported by the European Community. Arthritis Rheum 36:340-347
28. Claus R, Lenschow U, Külz T, Kotitschke A, Meiske D, Thiesen HJ, Lorenz P (2005) Congenital heart block associated with a maternal anti-HsEg5-like autoantibody. Rheumatology 44:691-693
29. Andrade LE, Chan EK, Peebles CL, Tan EM (1996) Two major autoantigen-antibody systems of the mitotic spindle apparatus. Athritis Rheum 39:1643-1653
30. Whitehead CM, Winkfein RJ, Fritzler MJ, Battner JB (1996) The spindle kinesin-like protein HsEg5 is an autoantigen in systemic lupus erythematosus. Arthritis Rheum 39:1635-1642
31. cdc2 regulates spindle association of human Eg5, a kinesin-related motor essential for bipolar spindle formation in vivo. Cell 83:1159-1169
32. Michaëlsson M, Engle MA (1972) Congenital heart block: an international study of the natural history. In: Brest AN, Engle MA (eds) Cardiovascular clinics. Davis, Philadelphia, pp 85-101
33. Ramsey-Goldman R, Hom D, Deng JS, Ziegler GC, Kahl LE, Steen VD, LaPorte RE, Medsger TA Jr (1986) Anti-SS-A antibodies and fetal outcome in maternal systemic lupus erythematosus. Arthritis Rheum 29:1269-1273
34. Taylor PV, Taylor KF, Norman A, Griffiths S, Scott JS (1988) Prevalence of maternal Ro (SS-A) and La (SS-B) autoantibodies in relation to congenital heart block. Br J Rheumatol 27:128-132
35. Mavragani CP, Ioannidis JPA, Tzioufas AG, Hantoumi EE, Moutsopoulos HM (1999) Recurrent pregnancy loss and autoantibody profile in autoimmune diseases. Rheumatology 38:1228-1233
36. Gordon P, Khamashta MA, Rosenthal E, Simpson JM, Sharland G, Brucato A, Franceschini F, De Bosschere K, Meheus L, Meroni PL, Hughes GRV, Buyon J (2004) Anti-52 kDa Ro, anti-60 kDa Ro, and anti-La antibody profiles in neonatal lupus. J Rheumatol 31:2480-2487
37. Buyon JP, Winchester RJ, Slade SG, Arnett F, Copel J, Friedman D, Lockshin MD (1993) Identification of mothers at risk for congenital heart block and other neonatal lupus syndromes in their children. Comparison of enzyme-linked immunosorbent assay and immunoblot for measurement of anti-SS-A/Ro and anti-SS-B/La antibodies. Arthritis Rheum 36:1263-1273
38. Dörner T, Chaoui R, Feist E, Göldner B, Yamamoto K, Hiepe F (1995) Significantly increased maternal and fetal IgG autoantibody levels to 52 kD Ro (SS-A) and La (SS-B) in complete congenital heart block. J Autoimmun 8:675-684
39. Salomonsson S, Dörner T, Theander E, Bremme K, Larsson P, Wahren-Herlenius M (2002) A serologic marker for fetal risk of congenital heart block. Arthritis Rheum 46:1233-1241
40. McCauliffe DP, Yin H, Wang LX, Lucas L (1994) Autoimmune sera react with multiple epitopes on recombinant 52 and 60kDa Ro (SSA) proteins. J Rheumatol 21:1073-1080
41. Fritsch C, Hoebeke J, Dali H, Ricchiuti V, Isenberg DA, Meyer O, Muller S (2006) 52-kDa Ro/SSA epitopes preferentially recognized by antibodies from mothers of children with neonatal lupus and congenital heart block. Arthritis Res Ther 8(1):R4. DOI 10.1186/ar1848
42. Benson DW (2004) Genetics of atrioventricular conduction disease in humans. Anat Rec 280A(2):934-939
43. Whitehead CM, Rattner JB (1998) Expanding the role of HsEg5 within the mitotic and post-mitotic phases of the cell cycle. J Cell Sci 111:2551-2561
44. Sakowicz R, Finer JT, Beraud C, Crompton A, Lewis E, Fritsch A, Lee Y, Mak J, Moody R, Turincio R, Chabala JC, Gonzales P, Roth S, Weitman S, Wood KW (2004) Antitumor activity of a kinesin inhibitor. Cancer Res 64:327-3280
45. Harley JB, Kaine JL, Fox OF, Reichlin M, Gruber B (1985) Ro (SS-A) antibody and antigen in a patient with congenital complete heart block. Arthritis Rheum 28:1321-1325
46. Julkunen H, Eronen M (2001) Long-term outcome of mothers of children with isolated heart block in Finland. Arthritis Rheum 44:647-652
47. Saleeb S, Copel J, Friedman D, Buyon JP (1999) Comparison of treatment with fluorinated glucocorticoids to the natural history of autoantibody- associated congenital heart block: retrospective review of the research registry for neonatal lupus. Arthritis Rheum 42:2335-2345
48. Shinohara K, Miyagawa S, Fujita T, Aono T, Kidoguchi K (1999) Neonatal lupus erythematosus: results of maternal corticosteroid therapy. Obstet Gynecol 93:952-957
49. Derksen RHW, Meilof JF (1992) Anti-Ro/SSA and anti-La/SSB autoantibody levels in relation to systemic lupus erythematosus disease activity and congenital heart block. Arthritis Rheum 35:953-959
50. Van der Leij JN, Visser GH, Bink-Boelkens MT, Meilof JF, Kallenberg CG (1994) Successful outcome of pregnancy after treatment of maternal anti-Ro (SSA) antibodies with immunosuppressive therapy and plasmapheresis. Prenat Diagn 14:1003-1007
51. Barclay CS, French MA, Ross LD, Sokol RJ (1987) Successful pregnancy following steroid therapy and plasma exchange in a woman with anti-Ro (SSA) antibodies. Case report. Br J Obstet Gynaecol 94:369-371
52. Buyon JP, Swersky SH, Fox HE, Bierman FZ, Winchester RJ (1987) Intrauterine therapy for presumptive fetal myocarditis with acquired heart block due to systemic lupus erythematosus. Experience in a mother with a predominance of SSB (La) antibodies. Arthritis Rheum 30:44-49
53. Arroyave CM, Puente Ledezma F, Montiel Amoroso G, Martinez Garcia AC (1995) Myocardiopathy diagnosed in utero in a mother with SSA antibodies treated with plasmapheresis. Ginecol Obstet Mex 63:134-137
54. Feist E, Dörner T, Wagenmann A, Chaqui R, Rohde W, Burmester GR, Hiepe F (1996) High risk pregnancy in primary Sjögren's syndrome - successful management by plasmapheresis and dexamethasone. Z Rheumatol 55:127-132
55. Buyon J, Roubey R, Swersky S, Pompeo L, Parke A, Baxi L, Winchester R (1988) Complete congenital heart block: risk of recurrence and therapeutic approach to prevention. J Rheumatol 15:1104-1108
56. Müller-Ladner U, Benning K, Röther E, Lang B (1992) Neonatal lupus erythematosus as an example of passively acquired autoimmunity. Immun Infekt 20:117-121